| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 28 Feb 25 | EXEL Exelixis | Common Stock | Sell | Dispose S | No | No | 37.62 | 19,294 | 725.84 k | 10,778 |
| 28 Feb 25 | EXEL Exelixis | Common Stock | Option exercise | Acquire M | No | No | 19.77 | 19,294 | 381.44 k | 30,072 |
| 28 Feb 25 | EXEL Exelixis | Option Common Stock | Option exercise | Dispose M | No | No | 19.77 | 19,294 | 381.44 k | 0 |
| 27 Feb 25 | EXEL Exelixis | Common Stock | Sell | Dispose S | No | No | 38.13 | 54,514 | 2.08 mm | 10,778 |
| 27 Feb 25 | EXEL Exelixis | Common Stock | Option exercise | Acquire M | No | No | 19.77 | 23,347 | 461.57 k | 65,292 |
| 27 Feb 25 | EXEL Exelixis | Common Stock | Option exercise | Acquire M | No | No | 20.5 | 31,167 | 638.92 k | 41,945 |
| 27 Feb 25 | EXEL Exelixis | Option Common Stock | Option exercise | Dispose M | No | No | 19.77 | 23,347 | 461.57 k | 19,294 |
| 27 Feb 25 | EXEL Exelixis | Option Common Stock | Option exercise | Dispose M | No | No | 20.5 | 31,167 | 638.92 k | 0 |
| 13 Aug 24 | EXEL Exelixis | Common Stock | Other | Dispose J | No | No | 0 | 4,682 | 0.00 | 10,778 |
| 5 Jun 24 | STOK Stoke Therapeutics | Director Stock Option Common Stock | Grant | Acquire A | No | No | 16.41 | 7,639 | 125.36 k | 7,639 |
